Trials / Terminated
TerminatedNCT02335229
A Post Market Study to Assess the Spinal Modulation Dorsal Root Ganglion Stimulator System in Chronic Post Surgical Pain
A Post Market Observational Cohort Study to Assess the Performance of the Spinal Modulation Dorsal Root Ganglion Stimulator System for the Management of Chronic Post Surgical Pain
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
20-SMI-2013 is a post market, observational, questionnaire based study to assess the effectiveness of the commercially available Axium neurostimulator in the management of chronic post surgical pain
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Axium DRG Neurostimulator | Implantation with Axium DRG Neurostimulator |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
- First posted
- 2015-01-09
- Last updated
- 2019-04-29
- Results posted
- 2019-04-29
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02335229. Inclusion in this directory is not an endorsement.